Iroquois Capital Management, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX)

Filing Manager
Iroquois Capital Management, LLC
Reporting Manager
Richard Abbe
Security
BriaCell Therapeutics Corp. Common Shares, no par value
Symbol
BCTX
Shares outstanding
1,982,846 shares
Disclosed Ownership
98,944 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 15:10:03 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Iroquois Capital Management, LLC 3% 57,200 0 57,200 /s/ Richard Abbe Richard Abbe, President
Richard Abbe 5% 98,944 98,944 57,200 /s/ Richard Abbe Richard Abbe
Kimberly Page 3% 57,200 0 57,200 /s/ Kimberly Page Kimberly Page